Measles virus-induced immunosuppression in vitro is independent of complex glycosylation of viral glycoproteins and of hemifusion

被引:27
|
作者
Weidmann, A
Fischer, C
Ohgimoto, S
Rüth, C
ter Meulen, V
Schneider-Schaulies, S
机构
[1] Univ Wurzburg, Inst Virol & Immunobiol, D-97078 Wurzburg, Germany
[2] Univ Marburg, Inst Virol, D-35037 Marburg, Germany
关键词
D O I
10.1128/JVI.74.16.7548-7553.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Expression of the measles virus (Rn) F/H complex on the surface of viral particles, infected cells, or cells transfected to express these proteins (presenter cells [PC]) is necessary and sufficient to induce proliferative arrest in both human and rodent lymphoid cells (responder cells [RC]), This inhibition was found to occur independent of apoptosis and soluble mediators excluded by a pore size filter of 200 nm released from either PC or RC. We now show that reactive oxygen intermediates which might be released by RC or PC also do not contribute to MV-induced immunosuppression in vitro. Using an inhibitor of Golgi-resident mannosidases (deoxymannojirimycin), we found that complex glycosylation of the F and H proteins is not required for the induction of proliferative arrest of RC, As revealed by our previous studies, proteolytic cleavage of the MV F protein precursor into its Fl and F2 subunits, but not of F/H-mediated cellular fusion, was found to be required, since fusion-inhibitory peptides such as Z-D-Phe-L-Phe-Gly (Z-fFG) did not interfere with the induction of proliferative inhibition. We now show that Z-fFG inhibits cellular fusion at the stage of hemifusion by preventing lipid mixing of the outer membrane lager. These results provide strong evidence for a receptor-mediated signal elicited by the IMV Fin complex which can be uncoupled from its fusogenic activity is required for the induction of proliferative arrest of human lymphocytes.
引用
收藏
页码:7548 / 7553
页数:6
相关论文
共 50 条
  • [41] Transient control of a virus-induced immunopathology by genetic immunosuppression
    O Boyer
    J L Cohen
    B Bellier
    V Thomas-Vaslin
    D Klatzmann
    M-F Saron
    [J]. Gene Therapy, 2000, 7 : 1536 - 1542
  • [42] Transient control of a virus-induced immunopathology by generic immunosuppression
    Boyer, O
    Cohen, JL
    Bellier, B
    Thomas-Vaslin, V
    Klatzmann, D
    Saron, MF
    [J]. GENE THERAPY, 2000, 7 (18) : 1536 - 1542
  • [43] INFLUENCE OF IMMUNOSUPPRESSION ON ROSS RIVER VIRUS-INDUCED MYOSITIS
    SEAY, AR
    GRIFFIN, DE
    JOHNSON, RT
    [J]. NEUROLOGY, 1980, 30 (04) : 426 - 427
  • [44] ZINC AS A COFACTOR IN HUMAN IMMUNODEFICIENCY VIRUS-INDUCED IMMUNOSUPPRESSION
    FALUTZ, J
    TSOUKAS, C
    GOLD, P
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (19): : 2850 - 2851
  • [45] IMMUNOSUPPRESSION DURING VIRAL ONCOGENESIS .4. GENERATION OF SOLUBLE VIRUS-INDUCED IMMUNOLOGICAL SUPPRESSOR MOLECULES
    STRAYER, DS
    KORBER, K
    DOMBROWSKI, J
    [J]. JOURNAL OF IMMUNOLOGY, 1988, 140 (06): : 2051 - 2059
  • [46] THE ROLE OF N-GLYCOSYLATION IN CELL-FUSION INDUCED BY A VACCINIA RECOMBINANT VIRUS EXPRESSING BOTH MEASLES-VIRUS GLYCOPROTEINS
    MALVOISIN, E
    WILD, F
    [J]. VIROLOGY, 1994, 200 (01) : 11 - 20
  • [47] Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression
    Marie, JC
    Saltel, F
    Escola, JM
    Jurdic, P
    Wild, TF
    Horvat, B
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (21) : 11952 - 11961
  • [48] Mechanism of measles virus-induced suppression of inflammatory immune responses
    Marie, JC
    Kehren, J
    Trescol-Biémont, MC
    Evlashev, A
    Valentin, H
    Walzer, T
    Tedone, R
    Loveland, B
    Nicolas, JF
    Rabourdin-Combe, C
    Horvat, B
    [J]. IMMUNITY, 2001, 14 (01) : 69 - 79
  • [49] MEASLES VIRUS-INDUCED AUTOIMMUNE REACTIONS AGAINST BRAIN ANTIGEN
    TERMEULEN, V
    LIEBERT, UG
    [J]. INTERVIROLOGY, 1993, 35 (1-4) : 86 - 94
  • [50] MEASLES VIRUS-INDUCED SUPPRESSION OF LYMPHOCYTE-REACTIVITY INVITRO
    LUCAS, CJ
    GALAMA, JMD
    POSTMA, JU
    [J]. CELLULAR IMMUNOLOGY, 1977, 32 (01) : 70 - 85